INNOVIVA, INC. Investment Income, Amortization of Discount
INNOVIVA, INC. (INVA) reported Investment Income, Amortization of Discount of $6.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeAmortizationOfDiscount · last filed 2017-11-03
- 2017-09-30: Investment Income, Amortization of Discount 9 month $6.00K.
- 2016-09-30: Investment Income, Amortization of Discount 9 month $8.00K.
| Period end | Investment Income, Amortization of Discount 9 month |
|---|---|
| 2017-09-30 | $6.00K 10-Q · filed 2017-11-03 |
| 2016-09-30 | $8.00K 10-Q · filed 2017-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |